REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION

小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节

基本信息

  • 批准号:
    8084144
  • 负责人:
  • 金额:
    $ 37.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-15 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Natural killer (NK) cells are innate lymphocytes that play a pivotal role in early anti-pathogen host defense and are particularly important in mediating resistance to viral infections. Indeed, humans with selective NK cell deficiencies experience significant difficulty with herpesviruses infections. The ability of NK cells to kill abnormal cells and produce immunomodulatory cytokines and chemokines uniquely positions them to not only participate in the initial defense against intracellular pathogens but also to influence the subsequent adaptive immune response. In addition to killing infected cells and generating cytokines and chemokines, NK cells are stimulated to vigorously proliferate during viral infections. This proliferative response can be divided into three distinct phases: early nonspecific NK cell proliferation, preferential proliferation of NK cells that are able to recognize infected cells, and cessation of proliferation and contraction of the expanded NK cell population. The regulatory mechanisms involved in controlling these different phases of NK cell proliferation are poorly characterized. The long-term objective of these studies is to understand the in vivo regulation of NK cell proliferation and homeostasis during viral infections. Using murine cytomegalovirus (MCMV) infection as a model system, we propose to address several critical, unresolved issues in the in vivo regulation of NK cell proliferation and homeostasis including 1) the relative contributions of cytokines and NK cell activation receptors to viral-induced NK cell proliferation, 2) the mechanism by which NK cell activation receptor signaling augments cytokine-driven NK cell proliferation, and 3) the role of the adaptive immune system in the resolution of viral-induced NK cell proliferation. We contend that a clearer understanding of in vivo NK cell proliferation and homeostasis during viral infections will have broad translational implications and may lead to novel therapeutic interventions to modulate NK cells to either stimulate more effective responses (e.g., during intractable viral infections or solid organ malignancies) or down-regulate over-exuberant or inappropriate responses (e.g., during NK cell lymphoproliferative disorders or autoimmune diseases). Public Health Relevance: Our innate immune system provides early resistance to viral infections while the more specific adaptive immune system is being activated. The overall objective of the proposed studies is to understand the regulation of one important type of cell in our innate immune response, natural killer cells, during viral infections. A more complete understanding of natural killer cell homeostasis during viral infections may lead to new ways to modulate natural killer cell responses during viral infections or autoimmune disorders.
描述(由申请人提供):自然杀伤(NK)细胞是先天性淋巴细胞,在早期抗病原体宿主防御中发挥关键作用,在介导对病毒感染的抵抗力方面尤为重要。事实上,患有选择性NK细胞缺陷的人在疱疹病毒感染方面遇到了很大的困难。NK细胞杀死异常细胞并产生免疫调节细胞因子和趋化因子的能力使其独特地不仅参与对细胞内病原体的初始防御,而且影响随后的适应性免疫应答。除了杀死受感染的细胞并产生细胞因子和趋化因子外,NK细胞在病毒感染期间被刺激剧烈增殖。这种增殖反应可以分为三个不同的阶段:早期非特异性NK细胞增殖,能够识别感染细胞的NK细胞的优先增殖,以及扩增的NK细胞群体的增殖和收缩的停止。参与控制NK细胞增殖的这些不同阶段的调节机制的特征很差。这些研究的长期目标是了解病毒感染期间NK细胞增殖和稳态的体内调节。以小鼠巨细胞病毒(MCMV)感染为模型系统,我们提出了在体内NK细胞增殖和稳态调节中几个关键的、未解决的问题,包括1)细胞因子和NK细胞活化受体对病毒诱导的NK细胞增殖的相对贡献,2)NK细胞活化受体信号传导增强丝氨酸驱动的NK细胞增殖的机制,以及3)适应性免疫系统在解决病毒诱导的NK细胞增殖中的作用。我们认为,更清楚地了解病毒感染期间体内NK细胞增殖和稳态将具有广泛的翻译意义,并可能导致新的治疗干预来调节NK细胞,以刺激更有效的反应(例如,在顽固性病毒感染或实体器官恶性肿瘤期间)或下调过度旺盛或不适当的反应(例如,在NK细胞淋巴增生性疾病或自身免疫性疾病期间)。公共卫生相关性:我们的先天免疫系统提供了对病毒感染的早期抵抗力,而更特异的适应性免疫系统正在被激活。拟议研究的总体目标是了解在病毒感染期间,我们先天免疫反应中一种重要类型的细胞-自然杀伤细胞-的调节。对病毒感染过程中自然杀伤细胞稳态的更全面理解可能会导致在病毒感染或自身免疫性疾病过程中调节自然杀伤细胞反应的新方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony R French其他文献

Anthony R French的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony R French', 18)}}的其他基金

Pediatric Infectious Diseases and Immunity Training Program
小儿传染病及免疫训练计划
  • 批准号:
    10187498
  • 财政年份:
    2014
  • 资助金额:
    $ 37.24万
  • 项目类别:
Pediatric Infectious Diseases and Immunity Training Program
小儿传染病及免疫训练计划
  • 批准号:
    10646336
  • 财政年份:
    2014
  • 资助金额:
    $ 37.24万
  • 项目类别:
Pediatric Infectious Diseases and Immunity Training Program
小儿传染病及免疫训练计划
  • 批准号:
    10413963
  • 财政年份:
    2014
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    8964503
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    8287164
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    7885469
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    7740883
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    8486372
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
REGULATION OF VIRAL-INDUCED NK CELL PROLIFERATION DURING MURINE CMV INFECTION
小鼠 CMV 感染期间病毒诱导的 NK 细胞增殖的调节
  • 批准号:
    9263748
  • 财政年份:
    2009
  • 资助金额:
    $ 37.24万
  • 项目类别:
INNATE IMMUNE RECEPTOR ANTAGONISM BY ORTHOPOXVIRUS PROTEINS
正痘病毒蛋白的先天免疫受体拮抗作用
  • 批准号:
    8130610
  • 财政年份:
    2008
  • 资助金额:
    $ 37.24万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.24万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了